Yuva Cosmoderm Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 0.12 M
- Company Age 11 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.85 Cr
- Satisfied Charges ₹ 3.27 Cr
- Revenue Growth -41.59%
- Profit Growth -2.65%
- Ebitda -79.90%
- Net Worth -22.74%
- Total Assets -12.20%
About Yuva Cosmoderm
Yuva Cosmoderm Private Limited (YCPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 February 2014 and has a history of 11 years. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹2.85 Cr. The company has closed loans amounting to ₹3.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dilip Hemnani and Munira Merchant serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100PN2014PTC150623
- Company No.
150623
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Yuva Cosmoderm?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Hemnani  | Director | 13-Feb-2014 | Current |
| Munira Merchant | Director | 18-Oct-2023 | Current |
Financial Performance of Yuva Cosmoderm.
Yuva Cosmoderm Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 41.59% decrease. The company also saw a slight decrease in profitability, with a 2.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yuva Cosmoderm?
In 2019, Yuva Cosmoderm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr. Hemnani's Cosmoderm (India) Private LimitedDilip Hemnani is a mutual person
Charges (Loans)
₹2.85 Cr
₹3.27 Cr
Charges Breakdown by Lending Institutions
- Others : 2.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2020 | Others | ₹2.85 Cr | Open |
| 30 Jun 2014 | Reliance Capital Ltd | ₹4.56 M | Satisfied |
| 30 Jun 2014 | Reliance Capital Ltd | ₹4.56 M | Satisfied |
| 30 Jun 2014 | Reliance Capital Ltd | ₹4.56 M | Satisfied |
| 28 Apr 2014 | Icici Bank Limited | ₹1.90 Cr | Satisfied |
How Many Employees Work at Yuva Cosmoderm?
Unlock and access historical data on people associated with Yuva Cosmoderm, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yuva Cosmoderm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yuva Cosmoderm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
